Endika Encinas-Martin

Gasteiz / Vitoria, PV 01006, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Synthesis and biological evaluation of novel fused pyridopyrimidine derivatives as topoisomerase I inhibitors and as potential antitumor agents: promising results in lung, ovary and gastric cancer.

Synthesis and biological evaluation of novel fused pyridopyrimidine derivatives as topoisomerase I inhibitors and as potential antitumor agents: promising results in lung, ovary and gastric cancer.

Journal: European journal of medicinal chemistry

Published: December 29, 2025

A patent review of topoisomerase 1 inhibitors (2021-present).

A patent review of topoisomerase 1 inhibitors (2021-present).

Journal: Expert opinion on therapeutic patents

Published: November 14, 2025

Investigational DNA topoisomerase I inhibitors for colorectal cancer: preclinical and early phase developments.

Investigational DNA topoisomerase I inhibitors for colorectal cancer: preclinical and early phase developments.

Journal: Expert opinion on investigational drugs

Published: July 19, 2025

Synthesis, biological and computational evaluation of novel cyanomethyl vinyl ether derivatives.

Synthesis, biological and computational evaluation of novel cyanomethyl vinyl ether derivatives.

Journal: Frontiers in pharmacology

Published: November 24, 2023

Antileishmanial Effect of 1,5- and 1,8-Substituted Fused Naphthyridines.

Antileishmanial Effect of 1,5- and 1,8-Substituted Fused Naphthyridines.

Journal: Molecules (Basel, Switzerland)

Published: November 04, 2023

Hydrogen sulphide-triggered theranostic prodrugs based on the dynamic chemistry of tetrazines.

Hydrogen sulphide-triggered theranostic prodrugs based on the dynamic chemistry of tetrazines.

Journal: Chemical communications (Cambridge, England)

Published: April 14, 2022

The design and discovery of topoisomerase I inhibitors as anticancer therapies.

The design and discovery of topoisomerase I inhibitors as anticancer therapies.

Journal: Expert opinion on drug discovery

Published: March 24, 2022

Naphthyridine Derivatives Induce Programmed Cell Death in Naegleria fowleri.

Naphthyridine Derivatives Induce Programmed Cell Death in Naegleria fowleri.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: September 06, 2021

A Dual-Sensor-Based Screening System for In Vitro Selection of TDP1 Inhibitors.

A Dual-Sensor-Based Screening System for In Vitro Selection of TDP1 Inhibitors.

Journal: Sensors (Basel, Switzerland)

Published: June 10, 2021

Dynamic Nucleophilic Aromatic Substitution of Tetrazines.

Dynamic Nucleophilic Aromatic Substitution of Tetrazines.

Journal: Angewandte Chemie (International ed. in English)

Published: May 08, 2021

Fused chromeno and quinolino[1,8]naphthyridines: Synthesis and biological evaluation as topoisomerase I inhibitors and antiproliferative agents.

Fused chromeno and quinolino[1,8]naphthyridines: Synthesis and biological evaluation as topoisomerase I inhibitors and antiproliferative agents.

Journal: Bioorganic & medicinal chemistry

Published: February 12, 2021

A patent review of topoisomerase I inhibitors (2016-present).

A patent review of topoisomerase I inhibitors (2016-present).

Journal: Expert opinion on therapeutic patents

Published: January 21, 2021

Showing 1-12 of 20

Last Updated: 09/26/2026